Skip to main content
Premium Trial:

Request an Annual Quote

Exact Sciences Files Shelf Registration for Sale of Securities

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exact Sciences announced after the close of the market on Tuesday that it has filed a universal shelf registration for the sale from time to time of up to $150 million in securities.

In the form S-3 filed with the US Securities and Exchange Commission, the company said that proceeds from the sale will be used for general corporate purposes and working capital, which includes funding efforts to obtain clearance from the US Food and Drug Administration of its stool-based DNA colorectal cancer screening product.

Exact Sciences said in a statement that the registration statement has not yet become effective and added that it has no immediate plans to offer securities under the shelf registration. Terms of any offering will be determined at the time of the offering.

In April, the Madison, Wis.-based molecular diagnostics firm completed a public offering of 4.2 million shares of its common stock at $4.50 to raise about $17.6 million in net proceeds.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.